ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: ABT

GSK and ABT expand personalized medicine pact for new cancer diagnostic

GSK and ABT expand personalized medicine pact for new cancer diagnostic

November 29, 2011 11:35 am by | 0 Comments

 A GlaxoSmithKline (NYSE:GSK) cancer drug program will be developed with a new companion diagnostic from Abbott (NYSE:ABT) as GSK moves to broaden its reach in personalized medicine.Abbott recently announced it ... Read more
Japanese trial for Abbott dissolvable stent gets first patient

Japanese trial for Abbott dissolvable stent gets first patient

August 17, 2011 3:02 pm by | 0 Comments

Abbott (NYSE:ABT) enrolled its first patients in a Japanese trial of the Absorb bioresorbable vascular scaffold.The Absorb stent opens clogged blood vessels and provides support to restore blood flow, and ... Read more
Abbott, Boston Scientific claim 64 percent of U.S. drug-eluting stent market

Abbott, Boston Scientific claim 64 percent of U.S. drug-eluting stent market

August 9, 2011 4:30 pm by | 0 Comments

Abbott Laboratories (NYSE:ABT) and Boston Scientific Corp. (NYSE:BSX) came out as the big players in the U.S. drug-eluting stent market, together staking claim to more than half of all DES ... Read more
Abbott stock down despite strong Q2 sales, earnings

Abbott stock down despite strong Q2 sales, earnings

July 20, 2011 4:06 pm by | 0 Comments

There’s no pleasing some people. Abbott (NYSE:ABT) shares were down on Wall Street today, despite the health care products giant reporting strong second-quarter sales and earnings figures ’ including a ... Read more
Abbott products nabbed in latest of low-cost med device thefts

Abbott products nabbed in latest of low-cost med device thefts

June 27, 2011 4:41 pm by | 0 Comments

An unknown bandit made off with a trailer shipment of Abbot Laboratories’ (NYSE:ABT) blood glucose monitoring products, and the company is working with law enforcement officials to get it back.In ... Read more
Abbott slicing 1,900 jobs out of its pharmaceuticals division

Abbott slicing 1,900 jobs out of its pharmaceuticals division

January 26, 2011 3:42 pm by | 0 Comments

Abbott had solid earnings to report, but problems in the pharmaceuticals portion of its business are triggering job cuts. About 2 percent of the company's global workforce will be let ... Read more
Abbott wants FDA OK to use carotid stent in standard-risk patients

Abbott wants FDA OK to use carotid stent in standard-risk patients

January 25, 2011 12:32 pm by | 0 Comments

Abbott Laboratories Inc. (NYSE:ABT) goes before a Food & Drug Administration panel today, seeking to expand the indication for its RX Acculink carotid artery stent. ... Read more
Cypher matches Xience V? So says a new Cordis study

Cypher matches Xience V? So says a new Cordis study

September 28, 2010 12:47 am by | 0 Comments

Citing results from the Sort Out IV trial, a head-to-head comparison of the two drug-eluting stents, Cordis chief scientific officer Dr. Campbell Rogers said the study confirms "the excellent sustained ... Read more
Abbott’s Q2 sales surge, but profits flat

Abbott’s Q2 sales surge, but profits flat

July 21, 2010 4:33 pm by | 0 Comments

Abbott (NYSE:ABT) posted flat second-quarter earnings despite a nearly 18 percent increase to its top line.The Abbott Park, Ill.-based medical products conglomerate reported sales of $8.83 billion for the three ... Read more
Abbott trims stent operations

Abbott trims stent operations

June 17, 2010 1:22 pm by | 0 Comments

Abbott Laboratories (NYSE:ABT) laid off 120 workers from its California stent-making operation.The Abbott Park, Ill.-based company laid off 101 workers from its Temecula and Murrieta vascular stent manufacturing facilities in ... Read more
New device study: Promus Element v. Xience Prime

New device study: Promus Element v. Xience Prime

May 26, 2010 7:41 pm by | 0 Comments

Boston Scientific Corp. (NYSE:BSX) set out to compare its new Promus Element drug-eluting stent system with Abbott’s (ABT) Xience Prime.The BSX-funded study will evaluate coronary revascularization outcomes in a 2,980-patient ... Read more
Morning Read: One month to apply for $5 million

Morning Read: One month to apply for $5 million

May 24, 2010 8:14 am by | 0 Comments

Highlights of the important and the interesting from the world of healthcare:Onemonthto apply for $5 million: Small drug and biomedical research firms will have a one-month window to apply for ... Read more
Abbott’s intraocular lens approved by Food & Drug Administration

Abbott’s intraocular lens approved by Food & Drug Administration

March 10, 2010 2:23 pm by | 0 Comments

Abbott (NYSE:ABT) won PMA clearance from the Food & Drug Administration for its TECNIS Multifocal 1-Piece intraocular lens, which the federal watchdog approved for treating cataract patients.The Abbott Park, Ill.-based ... Read more
Major study of carotid stents may help local medical device makers

Major study of carotid stents may help local medical device makers

February 26, 2010 6:51 pm by | 0 Comments

Local medical device companies, including Boston Scientific Corp., Lumen Biomedical Inc. and ev3 Inc. in Plymouth, Minn. may benefit from a major government-funded study that concludes carotid stents are equally ... Read more
Johnson & Johnson can’t proceed with Guidant acquisition suit

Johnson & Johnson can’t proceed with Guidant acquisition suit

February 22, 2010 4:12 am by | 0 Comments

A federal judge denied Johnson & Johnson's bid to revive its $5.5 billion anti-competition and breach of contract lawsuit against Boston Scientific Corp. and Abbott over its abortive attempt to ... Read more